Kasper Langebjerg Andersen
- Molecular Biology
- Cancer Research top 10%
- Oncology top 10%
- Genetics top 10%
- Public Health, Environmental and Occupational Health
- Co-authors
- Kathleen CollinsAman U. BuzdarPaul P. CarboneR. T. ChlebowskiMatthew L. BaumI. Craig HendersonO AbeMartin D. Abeloff
- Topics
- RNA modifications and cancer (7 papers)RNA and protein synthesis mechanisms (5 papers)Estrogen and related hormone effects (3 papers)
- Cited by
- Cancer ResearchOncologyGenetics
- Partner nations
- DenmarkUnited StatesUnited Kingdom
In The Last Decade
Kasper Langebjerg Andersen
16 papers receiving 913 citations
Peers
Comparison fields: 5 of 90
- Molecular Biology 418
- Cancer Research 295
- Oncology 283
- Genetics 214
- Public Health, Environmental and Occupational Health 96
Countries citing papers authored by Kasper Langebjerg Andersen
This map shows the geographic impact of Kasper Langebjerg Andersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kasper Langebjerg Andersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kasper Langebjerg Andersen more than expected).
Fields of papers citing papers by Kasper Langebjerg Andersen
This network shows the impact of papers produced by Kasper Langebjerg Andersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kasper Langebjerg Andersen. The network helps show where Kasper Langebjerg Andersen may publish in the future.
Co-authorship network of co-authors of Kasper Langebjerg Andersen
This figure shows the co-authorship network connecting the top 25 collaborators of Kasper Langebjerg Andersen. A scholar is included among the top collaborators of Kasper Langebjerg Andersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kasper Langebjerg Andersen. Kasper Langebjerg Andersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 37 | |
| 3 | 14 | |
| 4 | 8 | |
| 5 | 49 | |
| 6 | 9 | |
| 7 | 63 | |
| 8 | 19 | |
| 9 | 8 | |
| 10 | 95 | |
| 11 | 1 | |
| 12 | 5 | |
| 13 | 89 | |
| 14 | 2 | |
| 15 | 6 | |
| 16 | 52 | |
| 17 | Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women | 481 |
About Kasper Langebjerg Andersen
Kasper Langebjerg Andersen is a scholar working on Pharmacology, Molecular Medicine and Molecular Biology, having authored 17 papers that have together received 938 indexed citations. Recurring topics across this work include RNA modifications and cancer (7 papers), RNA and protein synthesis mechanisms (5 papers) and Estrogen and related hormone effects (3 papers). The work is most often cited by research in Cancer Research (295 citations), Oncology (283 citations) and Genetics (214 citations). Kasper Langebjerg Andersen has collaborated with scholars based in Denmark, United States and United Kingdom. Frequent co-authors include Kathleen Collins, Aman U. Buzdar, Paul P. Carbone, R. T. Chlebowski, Matthew L. Baum, I. Craig Henderson, O Abe, Martin D. Abeloff, J. Carpenter and Rory Collins. Their work appears in journals such as Nucleic Acids Research, Blood and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.